SG11201807811RA - Food compositions for weaning - Google Patents

Food compositions for weaning

Info

Publication number
SG11201807811RA
SG11201807811RA SG11201807811RA SG11201807811RA SG11201807811RA SG 11201807811R A SG11201807811R A SG 11201807811RA SG 11201807811R A SG11201807811R A SG 11201807811RA SG 11201807811R A SG11201807811R A SG 11201807811RA SG 11201807811R A SG11201807811R A SG 11201807811RA
Authority
SG
Singapore
Prior art keywords
international
bacteria
davis
pct
probiotic
Prior art date
Application number
SG11201807811RA
Inventor
David Kyle
Samara Freeman-Sharkey
Steven Frese
Original Assignee
Evolve Biosystems Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Evolve Biosystems Inc filed Critical Evolve Biosystems Inc
Publication of SG11201807811RA publication Critical patent/SG11201807811RA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
    • A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
    • A23K10/18—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/163—Sugars; Polysaccharides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/30—Feeding-stuffs specially adapted for particular animals for swines
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/60—Feeding-stuffs specially adapted for particular animals for weanlings
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L11/00—Pulses, i.e. fruits of leguminous plants, for production of food; Products from legumes; Preparation or treatment thereof
    • A23L11/05—Mashed or comminuted pulses or legumes; Products made therefrom
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
    • A23L19/10—Products from fruits or vegetables; Preparation or treatment thereof of tuberous or like starch containing root crops
    • A23L19/105—Sweet potatoes
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/125—Casei
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/173—Reuteri
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/51—Bifidobacterium
    • A23V2400/517—Bifidum
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/51—Bifidobacterium
    • A23V2400/519—Breve
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/51—Bifidobacterium
    • A23V2400/529—Infantis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/51—Bifidobacterium
    • A23V2400/533—Longum

Abstract

INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property -, Organization M1111101110101011111 HO 11111 0111011111011011100 111111 10 EDO IIE III 11 International Bureau ... .1 j ..... .....!;,,, (10) International Publication Number (43) International Publication Date WO 2017/156548 Al 14 September 2017 (14.09.2017) WIP0 I PCT (51) International Patent Classification: A61K 35/74 (2015.01) A61K 31/00 (2006.01) (21) International Application (22) International Filing Date: (25) Filing Language: (26) Publication Language: (30) Priority Data: 62/307,425 11 March (71) Applicant: EVOLVE BIOSYSTEMS 2121 2nd Street, Suite B107, (72) Inventors: KYLE, David; 95445 (US). FREEMAN-SHARKEY, Hamel Street, Davis, CA 95618 9163 Olmos Lane, Davis, CA (81) Designated States (unless otherwise indicated, for every A61K 31/702 (2006.01) kind of national protection available): AE, AG, AL, AM, A61K 35/00 (2006.01) AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, Number: DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, PCT/US2017/022207 HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, 13 March 2017 (13.03.2017) MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, English RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, English TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. 2016 (11.03.2016) US (84) Designated States (unless otherwise indicated, for every kind of regional protection available): ARIPO (BW, GH, INC. [US/US]; GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, Davis, CA 95618 (US). TZ, UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, P.O. Box 119, Gualala, CA TJ, TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, Samara; 5248 DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, (US). FRESE, Steven; LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, 95616 (US). SM, TR), OAPI (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG). W. et al.; Hunton and Willi- Published: Avenue, NW, Washington, — with international search report (Art. 21(3)) Agents: PEARLMAN, Anne, (74) ams LLP, 2200 Pennsylvania DC 20036 (US). = (54) Title: FOOD COMPOSITIONS FOR WEANING 7007 Iffi Other ::ff Iff ,ysipelotrichaceee Enterococcaceae Vaillonellaceae ff Staphylococcaceae , achnospiraceae \" , ostriCiaceae l'reptococcaceae Bacteroidaceae ff Enterobacteriaceae 410511111111 — 1.0. — '''' . ...... - III Bifidobacteriaceae 0 .'` '\" r, 4 , i c o 1ff 0§ 4 , g' Day of Life FIG. 3A herein relate generally to digestive healthcare, and more particularly, to the feeding of who are making a transition from a inicrobiome with lower diversity to a microbiome with relate to certain foods comprising a fermentable nutritional component and a probiotic compon - is selected, based on genetic and/or metabolic criteria, to specifically metabolize any Free Sugar Acids (FAAs) or peptides that accumulate as a result of the fermentable nutritional component - GC 71' kin (57) : The inventions described il f ) mammals, particularly human infants, 1-1 ---- higher diversity. These inventions IN ent, where the probiotic component C Monomers (FSMs) and Free Amino N in the lower intestine, where they otherwise might be left in the environment to be fermented and metabolized by less adapted/oppor - 0 tunistic bacteria, creating blooms of deleterious intestinal bacteria and shifting the microbiome to a potentially dysbiotic state. The ,..1: present inventions provide combinations of foods and probiotic bacteria that can protect the mammalian gut from blooms of patho - .,- genic bacteria.
SG11201807811RA 2016-03-11 2017-03-13 Food compositions for weaning SG11201807811RA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201662307425P 2016-03-11 2016-03-11
PCT/US2017/022207 WO2017156548A1 (en) 2016-03-11 2017-03-13 Food compositions for weaning

Publications (1)

Publication Number Publication Date
SG11201807811RA true SG11201807811RA (en) 2018-10-30

Family

ID=59789749

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201807811RA SG11201807811RA (en) 2016-03-11 2017-03-13 Food compositions for weaning

Country Status (9)

Country Link
US (1) US20190069586A1 (en)
EP (1) EP3426269A4 (en)
CN (1) CN109069549A (en)
AU (1) AU2017230185A1 (en)
BR (1) BR112018068274A2 (en)
CA (1) CA3017371A1 (en)
MX (1) MX2023005167A (en)
SG (1) SG11201807811RA (en)
WO (1) WO2017156548A1 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ612504A (en) 2010-12-31 2015-02-27 Abbott Lab Methods for reducing the incidence of oxidative stress using human milk oligosaccharides, vitamin c and anti-inflammatory agents
US9539269B2 (en) 2010-12-31 2017-01-10 Abbott Laboratories Methods for decreasing the incidence of necrotizing enterocolitis in infants, toddlers, or children using human milk oligosaccharides
CN107595860A (en) 2011-07-22 2018-01-19 雅培制药有限公司 For preventing injury of gastrointestinal tract and/or promoting the galactooligosaccharide of intestines and stomach reparation
WO2013032674A1 (en) 2011-08-29 2013-03-07 Abbott Laboratories Human milk oligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract
US20210161924A1 (en) * 2018-06-19 2021-06-03 Evolve Biosystems, Inc. Novel oligosaccharides for use in prebiotic applications
EP3718416A1 (en) * 2019-04-03 2020-10-07 COREE S.r.l. Production method to increase bioavailability of sugars from natural complex polysaccharides for human, animal and agricultural purposes
EP3958844A4 (en) * 2019-04-22 2023-01-04 Pendulum Therapeutics, Inc. Microbial compositions and methods for greater tolerability and prolonged shelf life
ES1240969Y (en) * 2019-09-18 2020-07-30 Jennewein Biotechnologie Gmbh CEREAL COMPOSITIONS CONTAINING OLIGOSACCHARIDS FROM HUMAN MILK
GB201914384D0 (en) * 2019-10-04 2019-11-20 Mars Inc Microbiome Interventions
AU2021254477A1 (en) * 2020-04-08 2022-11-10 Megmilk Snow Brand Co., Ltd. Composition for improving gut microbiota
BE1028802B1 (en) 2020-11-16 2022-06-14 Le Centre Wallon De Rech Agronomiques DEVELOPMENT OF A SYMBIOTIC COMPOSITION AS A FEED ADDITIVE FOR PIGLETS OR PREGNANT SOWS TO MODULATE THE INTESTINAL MICROBIOTA OF PIGLETS AT WEANING TIME
US11801273B2 (en) 2020-12-23 2023-10-31 Church & Dwight Co., Inc. Compositions and methods to increase production of isothiocyanates

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20032391A1 (en) * 2003-12-05 2005-06-06 Consiglio Nazionale Ricerche MENSA OLIVES CONTAINING PROBIOTIC MICRO-ORGANISMS.
EP1776877A1 (en) * 2005-10-21 2007-04-25 N.V. Nutricia Method for stimulating the intestinal flora
US8197872B2 (en) * 2007-05-17 2012-06-12 The Regents Of The University Of California Human milk oligosaccharides to promote growth of beneficial gut bacteria
US20110183062A1 (en) * 2007-09-07 2011-07-28 Silja Ursel Range of shelf stable baby foods in which the content of undesirable ingredients is controlled by stage
WO2009102193A1 (en) * 2008-02-12 2009-08-20 N.V. Nutricia A composition comprising bifidobacterium infantis and fructo- and galacto-oligosaccharides for the prevention of intestinal discomfort in infants
EP2668854B1 (en) * 2008-03-28 2015-07-01 Nestec S.A. Probiotics for use in expecting female mammals for enhancing the immunity of their offsprings
BRPI1008280A2 (en) * 2009-02-24 2015-08-25 Ritter Pharmaceuticals Inc Prebiotic Formulations and Methods of Use
IT1395328B1 (en) 2009-08-26 2012-09-14 Alpiflor S R L COMPOSITION OF BUTIRRIC ACID MIXED WITH PROBIOTICS AND PREBIOTICS
NZ613165A (en) * 2010-12-31 2015-02-27 Abbott Lab Nutritional formulations including human milk oligosaccharides and long chain polyunsaturated fatty acids and uses thereof
ITMI20110793A1 (en) * 2011-05-09 2012-11-10 Probiotical Spa STRAINS OF PROBIOTIC BACTERIA AND SYNBIOTIC COMPOSITION CONTAINING THEMSELVES INTENDED FOR THE BABY FOOD.
JP6129821B2 (en) * 2011-05-13 2017-05-17 グリコシン リミテッド ライアビリティー カンパニー Use of purified 2'-fucosyl lactose, 3-fucosyl lactose, and lactodifucotetraose as prebiotics
MX2014000458A (en) * 2011-07-12 2014-05-01 Nestec Sa Probiotic for administration to healthy young mammals during the weaning period for improving tolerance to newly introduced food stuffs.
CN107595860A (en) * 2011-07-22 2018-01-19 雅培制药有限公司 For preventing injury of gastrointestinal tract and/or promoting the galactooligosaccharide of intestines and stomach reparation
WO2013032674A1 (en) * 2011-08-29 2013-03-07 Abbott Laboratories Human milk oligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract
CN104918624A (en) * 2012-11-26 2015-09-16 托马斯·朱利叶斯·波洛迪 Compositions for the restoration of a fecal microbiota and methods for making and using them
ES2895380T3 (en) * 2013-11-15 2022-02-21 Nestle Sa Compositions for use in the prevention or treatment of necrotizing enterocolitis in infants and young children
EP3082828B1 (en) * 2013-11-15 2022-03-02 Société des Produits Nestlé S.A. Compositions for use in the prevention or treatment of necrotizing enterocolitis in infants or young children born by c-section
US20150290260A1 (en) * 2014-04-10 2015-10-15 Mead Johnson Nutrition Company Methods of use for probiotics and prebiotics
EP3212181A1 (en) * 2014-10-27 2017-09-06 Nestec S.A. Nutritional compositions comprising sn-1 (3) monoacylglycerols for use in the treatment of malabsorption or maldigestion in infants or young children

Also Published As

Publication number Publication date
EP3426269A1 (en) 2019-01-16
EP3426269A4 (en) 2019-10-16
MX2023005167A (en) 2023-05-30
US20190069586A1 (en) 2019-03-07
CN109069549A (en) 2018-12-21
WO2017156548A1 (en) 2017-09-14
CA3017371A1 (en) 2017-09-14
AU2017230185A1 (en) 2018-10-04
BR112018068274A2 (en) 2019-01-15

Similar Documents

Publication Publication Date Title
SG11201807811RA (en) Food compositions for weaning
SG11201908367TA (en) Flavor modifiers for meat analog products
SG11201811227QA (en) Method for facilitating maturation of the mammalian immune system
SG11201807809XA (en) A transient commensal microorganism for improving gut health
SG11201908540PA (en) Stable antibody formulation
SG11201910096RA (en) Anti-cd3-binding domains and antibodies comprising them, and methods for their generation and use
SG11201807195VA (en) Compositions comprising bacterial blautia strains for treating visceral hypersensitivity
SG11201808709VA (en) T cell receptors
SG11201806002SA (en) Methods for extending the replicative capacity of somatic cells during an ex vivo cultivation process
SG11201810571RA (en) Compositions comprising bacterial strains
SG11201811490XA (en) Cd3 binding antibodies
SG11201806342SA (en) Glucagon and glp-1 co-agonists for the treatment of obesity
SG11201808710UA (en) Novel immunogenic cd1d binding peptides
SG11201810420YA (en) Antibodies to alpha-synuclein and uses thereof
SG11201805942UA (en) Compositions and methods for intravenous administration of 2-bromo-1-(3,3-dinitroazetidin-1-yl)ethanone
SG11201906853QA (en) Anti-rsv monoclonal antibody formulation
SG11201908418RA (en) Compositions and methods for selective elimination and replacement of hematopoietic stem cells
SG11201806057QA (en) Novel probiotic bacterial strain of lactobacillus plantarum and compositions and uses thereof in the treatment of inflammation
SG11201908657VA (en) Engineered gram-negative endolysins
SG11201903345WA (en) Extract of an herbal composition as antimicrobial and/or antibiofilm agent
SG11201811479RA (en) An antibacterial composition and a method of treating staphylococcal infections with the antibacterial composition
SG11201809100QA (en) Use of gram negative species to treat atopic dermatitis
SG11201908325PA (en) Process for the preparation of glucuronide drug-linkers and intermediates thereof
SG11201806127XA (en) Pharmaceutical or nutritional combination comprising beta-hydroxy-betamethylbutyrate
SG11201908691PA (en) Compounds and methods for the treatment of parasitic diseases